Pfizer to pay $55M to settle Wyeth illegal Protonix marketing case

Pfizer Inc. will pay $55 million plus interest to resolve allegations that Wyeth, a company acquired by the drug maker in 2009, illegally marketed a misbranded drug for off-label use, federal prosecutors in Boston said today. Wyeth manufactured and promoted Protonix, a proton pump inhibitor used by physicians to treat various forms of gastro-esophageal reflux disease, prosecutors said.

Read more about the Wyeth illegal Protonix marketing case…

0 Responses to “Pfizer to pay $55M to settle Wyeth illegal Protonix marketing case”

  1. Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 435 other followers

Contact Us:

Hissey Kientz, LLP

9442 Capital of Texas Hwy N.

Arboretum Plaza One, Suite 400

Austin, Texas 78759

Toll-free: (866) 275-4454

Facsimile: (512) 320-9101


Sponsored By:

Hissey Kientz, LLP (Austin, TX)

Attorney Michael Hissey is responsible for the content of this website.

%d bloggers like this: